肿瘤科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 肿瘤科威廉亚洲博彩公司

2016ACOG实践简报：乳腺良性疾病的诊断和管理

2016-07-19 美国妇产科医师学会

乳腺癌乳腺良性疾病

2016ACOG实践简报：乳腺良性疾病的诊断和管理

中文标题：

2016ACOG实践简报：乳腺良性疾病的诊断和管理

英文标题：

diagnosis and management of benign breast disorders

发布机构：

美国妇产科医师学会

发布日期：

2016-07-19

简要介绍：

2016ACOG实践简报：乳腺良性疾病的诊断和管理



相关资料下载：
[AttachmentFileName(sort=100, fileName=2016ACOG实践简报：乳腺良性疾病的诊断和管理)] GetToolGuiderByIdResponse(projectId=1, id=f18591c00123932d, title=2016ACOG实践简报：乳腺良性疾病的诊断和管理, enTitle=diagnosis and management of benign breast disorders, guiderFrom=, authorId=null, author=, summary=2016ACOG实践简报：乳腺良性疾病的诊断和管理, cover=, journalId=null, articlesId=null, associationId=357, associationName=美国妇产科医师学会, associationIntro=美国妇产科医师学会(ACOG)，前身为美国妇产科学院，是一个美国妇产科妇科专业医生的专业协会。ACOG拥有超过55000名会员，其中90% 的会员是在美国经执业认证的妇产科医生。Obstetrics & Gynecology是ACOG的官方刊物。通常被称为&ldquo;绿色杂志&rdquo;。 American College of Obstetricians and Gynecologists, copyright=0, guiderPublishedTime=Tue Jul 19 15:01:30 CST 2016, originalUrl=, linkOutUrl=, content=2016ACOG实践简报：乳腺良性疾病的诊断和管理<div><br></div><div><br></div>, tagList=[TagDto(tagId=285, tagName=乳腺癌), TagDto(tagId=24004, tagName=乳腺良性疾病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=null, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3570, appHits=103, showAppHits=0, pcHits=1919, showPcHits=1893, likes=171, shares=2, comments=6, approvalStatus=1, publishedTime=Tue Jul 19 15:01:30 CST 2016, publishedTimeString=2016-07-19, pcVisible=1, appVisible=1, editorId=5295946, editor=kelly, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=kelly, createdTime=Tue Jul 19 15:01:30 CST 2016, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 11:10:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016ACOG实践简报：乳腺良性疾病的诊断和管理)])
2016ACOG实践简报：乳腺良性疾病的诊断和管理
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=147951, encodeId=c16d14e951a1, content=临床用的最多的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa571965590, createdName=1e149c40m79(暂无匿称), createdTime=Thu Oct 13 23:47:23 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122487, encodeId=73c912248e15, content=没有williamhill asia 医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:27:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105268, encodeId=4244105268f1, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:42:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105214, encodeId=ce7310521488, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95624, encodeId=18b89562464, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2016-10-13 1e149c40m79(暂无匿称)

    临床用的最多的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=147951, encodeId=c16d14e951a1, content=临床用的最多的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa571965590, createdName=1e149c40m79(暂无匿称), createdTime=Thu Oct 13 23:47:23 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122487, encodeId=73c912248e15, content=没有williamhill asia 医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:27:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105268, encodeId=4244105268f1, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:42:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105214, encodeId=ce7310521488, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95624, encodeId=18b89562464, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2016-09-11 1e10c84am36(暂无匿称)

    没有williamhill asia 医学指导还真不知道这些，得好好学习呀

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=147951, encodeId=c16d14e951a1, content=临床用的最多的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa571965590, createdName=1e149c40m79(暂无匿称), createdTime=Thu Oct 13 23:47:23 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122487, encodeId=73c912248e15, content=没有williamhill asia 医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:27:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105268, encodeId=4244105268f1, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:42:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105214, encodeId=ce7310521488, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95624, encodeId=18b89562464, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2016-08-27 zibozhouping

    先下手为强?，学习学习，参考相关知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=147951, encodeId=c16d14e951a1, content=临床用的最多的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa571965590, createdName=1e149c40m79(暂无匿称), createdTime=Thu Oct 13 23:47:23 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122487, encodeId=73c912248e15, content=没有williamhill asia 医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:27:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105268, encodeId=4244105268f1, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:42:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105214, encodeId=ce7310521488, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95624, encodeId=18b89562464, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2016-08-27 1e0f7307m29(暂无匿称)

    实用，特别实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=147951, encodeId=c16d14e951a1, content=临床用的最多的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa571965590, createdName=1e149c40m79(暂无匿称), createdTime=Thu Oct 13 23:47:23 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122487, encodeId=73c912248e15, content=没有williamhill asia 医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:27:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105268, encodeId=4244105268f1, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:42:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105214, encodeId=ce7310521488, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95624, encodeId=18b89562464, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2016-08-03 1dd8c52fm63(暂无匿称)

    下载啦！

    0

相关威廉亚洲博彩公司

中国晚期乳腺癌临床诊疗专家共识2016

中华医学杂志(National Medical Journal of China) · 2016-07-04

2015 ESMO临床实践威廉亚洲博彩公司 ：原发性乳腺癌的诊断、治疗与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2015-09-01

2016 ASCO：乳腺癌生存护理威廉亚洲博彩公司

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-30

2016 人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2016-04-12

2015 乳腺癌的临床试验终点事件的时间定义威廉亚洲博彩公司

国外肿瘤科相关专家小组（统称） · 2015-02-27

2014 乳腺癌骨转移和骨相关疾病临床诊疗专家共识

乳腺癌骨转移和骨相关疾病临床诊疗专家组 · 2014-12-03